RecruitingNCT06380686

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based


Sponsor

AIO-Studien-gGmbH

Enrollment

120 participants

Start Date

Nov 7, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective, open, non-interventional, multi-center clinical registry study with the aim to establish a comprehensive research platform reflecting the real-world treatment landscape for recurrent/metastatic head and neck tumor patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a research database (registry) study that collects blood samples and tumor tissue from patients with squamous cell carcinoma of the head and neck who are receiving palliative (non-curative) treatment. Researchers will use these samples to look for biological markers that might predict treatment outcomes. **You may be eligible if...** - You are 18 or older - You have confirmed squamous cell carcinoma of the head and neck (mouth, throat, voice box, or lower throat) - You are receiving palliative systemic treatment or best supportive care (curative treatment is not an option) - You consent within 4 weeks of starting first-line palliative treatment (or within 6 weeks of diagnosis if receiving supportive care only) **You may NOT be eligible if...** - There are no exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERdata collection

Demography, Social history, Riskfactors, Relevant medical history, Oncological family history, Disease \& treatment history, Molecular Pathology and Results, Treatment data, Response data, progession free survial, overall survival.


Locations(2)

Universitätsklinikum Essen

Essen, Germany

Onkologie/Studienzentrum am Raschplatz GbR

Hanover, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06380686


Related Trials